Author

N.-N. Lou

Observed names: N-N. Lou, N.N. Lou, Na Na Lou

Institution: Guangdong General Hospital

Observed institution: Guangdong General Hospital

OpenAlex ID: A5113784973

Response to tyrosine kinase inhibitors in advanced non-small-cell lung cancer with concomitant c-MET overexpression and EGFR mutation.

2016 · Na Na Lou, Yi-Long Wu, et al. · Journal of Clinical Oncology · 3

De Novo Met Overexpression Coexisting with Oncogenic Drivers in Advanced Non-Small-Cell Lung Cancer

2014 · N.N. Lou, J. Yang, et al. · Annals of Oncology · 2

454P Efficacy of crizotinib in NSCLC with concomitant ALK fusion and c-MET overexpression

2016 · R-L. Chen, N-N. Lou, et al. · Annals of Oncology

454P Efficacy of crizotinib in NSCLC with concomitant ALK fusion and c-MET overexpression

2016 · R.-L. Chen, N.-N. Lou, et al. · Annals of Oncology

472P Predictive and prognostic value of de novo MET expression in patients with advanced non-small cell lung cancer

2015 · A. Li, Y.F. Niu, et al. · Annals of Oncology

Works count: 5

Citation count: 5

H-index: 2

I10-index: